{"brief_title": "Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)", "brief_summary": "An investigational drug (MK0677) will be studied to determine whether it helps the memory and cognition of patients with Alzheimer's Disease.", "condition": "Alzheimer's Disease", "intervention_type": "Drug", "intervention_name": "MK0677", "criteria": "- Patients must have probable Alzheimer's disease of mild or moderate severity. - A brain scan and laboratory results must be consistent with Alzheimer's disease. - The patient must be otherwise medically healthy.", "gender": "All", "minimum_age": "50 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00074529.xml"}